Login
Home
Charts
Search
Watchlist
Products

Arvee Laboratories (India) Ltd

ARVEE·NSE
236.07+13.02%Tue, 22 Sept '26

Arvee Laboratories (India) Ltd

ARVEE
NSE
236.07
+13.02%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
256Cr
Close
Close Price
232.60
Industry
Industry
Chemicals - Speciality
PE
Price To Earnings
63.21
PS
Price To Sales
6.21
Revenue
Revenue
41Cr
Rev Gr TTM
Revenue Growth TTM
16.65%
PAT Gr TTM
PAT Growth TTM
195.62%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
98611139673101117
Growth YoY
Revenue Growth YoY%
-60.8-52.6-51.139.540.615.75.0-29.4-72.59.867.4130.3
Expenses
ExpensesCr
875911967381015
Operating Profit
Operating ProfitCr
111220000213
OPM
OPM%
7.76.812.914.512.13.93.64.53.516.610.214.5
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
001110000112
Tax
TaxCr
000000000001
PAT
PATCr
000110000212
Growth YoY
PAT Growth YoY%
-89.8-73.91,100.091.8366.7-37.5-41.7-81.9-99.01,120.0642.9894.1
NPM
NPM%
2.43.11.98.97.81.71.12.30.318.74.89.8
EPS
EPS
0.20.20.10.80.90.10.10.10.01.70.51.5
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
98611139673101117
Growth YoY
Revenue Growth YoY%
-60.8-52.6-51.139.540.615.75.0-29.4-72.59.867.4130.3
Expenses
ExpensesCr
875911967381015
Operating Profit
Operating ProfitCr
111220000213
OPM
OPM%
7.76.812.914.512.13.93.64.53.516.610.214.5
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
001110000112
Tax
TaxCr
000000000001
PAT
PATCr
000110000212
Growth YoY
PAT Growth YoY%
-89.8-73.91,100.091.8366.7-37.5-41.7-81.9-99.01,120.0642.9894.1
NPM
NPM%
2.43.11.98.97.81.71.12.30.318.74.89.8
EPS
EPS
0.20.20.10.80.90.10.10.10.01.70.51.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
273448554547406130383241
Growth
Revenue Growth%
106.828.438.814.9-17.34.3-14.952.1-50.526.8-18.116.6
Expenses
ExpensesCr
222941493941355427352836
Operating Profit
Operating ProfitCr
567666673435
OPM
OPM%
18.617.115.011.313.312.814.111.99.79.410.112.9
Other Income
Other IncomeCr
10001011111
Interest Expense
Interest ExpenseCr
333211000000
Depreciation
DepreciationCr
122222222111
PBT
PBTCr
112334362325
Tax
TaxCr
0-11011121100
PAT
PATCr
021223341234
Growth
PAT Growth%
111.5716.7-29.8107.81.616.5-3.960.0-74.5104.217.6195.6
NPM
NPM%
0.74.52.34.15.15.76.46.73.55.68.09.8
EPS
EPS
3.81.32.11.02.42.33.70.91.92.33.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
273448554547406130383241
Growth
Revenue Growth%
106.828.438.814.9-17.34.3-14.952.1-50.526.8-18.116.6
Expenses
ExpensesCr
222941493941355427352836
Operating Profit
Operating ProfitCr
567666673435
OPM
OPM%
18.617.115.011.313.312.814.111.99.79.410.112.9
Other Income
Other IncomeCr
10001011111
Interest Expense
Interest ExpenseCr
333211000000
Depreciation
DepreciationCr
122222222111
PBT
PBTCr
112334362325
Tax
TaxCr
0-11011121100
PAT
PATCr
021223341234
Growth
PAT Growth%
111.5716.7-29.8107.81.616.5-3.960.0-74.5104.217.6195.6
NPM
NPM%
0.74.52.34.15.15.76.46.73.55.68.09.8
EPS
EPS
3.81.32.11.02.42.33.70.91.92.33.7

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
4666111111111111
Reserves
ReservesCr
091113101317182023
Current Liabilities
Current LiabilitiesCr
1521171218149747
Non Current Liabilities
Non Current LiabilitiesCr
17942112222
Total Liabilities
Total LiabilitiesCr
36443734413939383843
Current Assets
Current AssetsCr
19272118262422172025
Non Current Assets
Non Current AssetsCr
17171616151517211818
Total Assets
Total AssetsCr
36443734413939383843
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
4666111111111111
Reserves
ReservesCr
091113101317182023
Current Liabilities
Current LiabilitiesCr
1521171218149747
Non Current Liabilities
Non Current LiabilitiesCr
17942112222
Total Liabilities
Total LiabilitiesCr
36443734413939383843
Current Assets
Current AssetsCr
19272118262422172025
Non Current Assets
Non Current AssetsCr
17171616151517211818
Total Assets
Total AssetsCr
36443734413939383843

Cash Flow

Standalone
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
46910213400
Investing Cash Flow
Investing Cash FlowCr
-1-1-3-3-10-1-2-11
Financing Cash Flow
Financing Cash FlowCr
-3-4-5-105-6-2000
Net Cash Flow
Net Cash FlowCr
012-36-5-11-20
Free Cash Flow
Free Cash FlowCr
3588-1-211-2-3
CFO To PAT
CFO To PAT%
259.5552.4417.9448.563.926.571.1348.3-9.6-4.7
CFO To EBITDA
CFO To EBITDA%
68.383.9153.1171.328.312.040.2124.7-5.7-3.8
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
46910213400
Investing Cash Flow
Investing Cash FlowCr
-1-1-3-3-10-1-2-11
Financing Cash Flow
Financing Cash FlowCr
-3-4-5-105-6-2000
Net Cash Flow
Net Cash FlowCr
012-36-5-11-20
Free Cash Flow
Free Cash FlowCr
3588-1-211-2-3
CFO To PAT
CFO To PAT%
259.5552.4417.9448.563.926.571.1348.3-9.6-4.7
CFO To EBITDA
CFO To EBITDA%
68.383.9153.1171.328.312.040.2124.7-5.7-3.8

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3435266112597158156148256
Price To Earnings
Price To Earnings
30.815.311.322.848.623.5150.972.858.563.2
Price To Sales
Price To Sales
0.70.60.61.33.11.65.24.14.76.2
Price To Book
Price To Book
2.42.11.42.95.23.55.45.04.47.6
EV To EBITDA
EV To EBITDA
6.56.84.810.521.913.353.542.346.135.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.828.121.328.730.735.828.338.235.240.440.4
OPM
OPM%
18.617.115.011.313.312.814.111.99.79.410.112.9
NPM
NPM%
0.74.52.34.15.15.76.46.73.55.68.09.8
ROCE
ROCE%
15.518.215.118.013.914.122.66.99.77.67.6
ROE
ROE%
36.97.713.812.312.510.814.73.66.97.57.5
ROA
ROA%
4.32.56.16.86.56.710.72.85.75.95.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3435266112597158156148256
Price To Earnings
Price To Earnings
30.815.311.322.848.623.5150.972.858.563.2
Price To Sales
Price To Sales
0.70.60.61.33.11.65.24.14.76.2
Price To Book
Price To Book
2.42.11.42.95.23.55.45.04.47.6
EV To EBITDA
EV To EBITDA
6.56.84.810.521.913.353.542.346.135.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.828.121.328.730.735.828.338.235.240.440.4
OPM
OPM%
18.617.115.011.313.312.814.111.99.79.410.112.9
NPM
NPM%
0.74.52.34.15.15.76.46.73.55.68.09.8
ROCE
ROCE%
15.518.215.118.013.914.122.66.99.77.67.6
ROE
ROE%
36.97.713.812.312.510.814.73.66.97.57.5
ROA
ROA%
4.32.56.16.86.56.710.72.85.75.95.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Arvee Laboratories (India) Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/urnrqkolgmysznxmcdobrl01.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/b27jijchilbxuk0wow5wzu5s.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/8b8chsy34cbtwdw8sxrokdi8.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/y9wryvbhnvfy3bw1uv7kwoae.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/yxtq0lemxosd5ddiorq0bw0d.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/6zkm74qfxxa84zpf977j54ar.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/16s246eprnlqnkcb0nmc8wjw.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/wyebs29bsa35q31pbyclko8x.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/18mqhp3oayjpifuz0276xpqz.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/m8c04morlxg1hzn05co3i3ry.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/rudhabzhf3zmo0ust7vkqp72.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/591vl2fq4fq8mfkoowuh23r4.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/rwo7mhw7k5mi7pgyge8kkhp4.pdf